Limits...
Cervical cancer screening with clinic-based Pap test versus home HPV test among Somali immigrant women in Minnesota: a pilot randomized controlled trial.

Sewali B, Okuyemi KS, Askhir A, Belinson J, Vogel RI, Joseph A, Ghebre RG - Cancer Med (2015)

Bottom Line: Test completion rates were measured at 3 months.Univariate and multivariate logistic regression models were used to explore factors associated with test completion (intention-to-treat analysis).Participants in the HPV test group were 14 times more likely to complete the test compared to those in the Pap test group (P = 0.0002).

View Article: PubMed Central - PubMed

Affiliation: Program in Health Disparities Research, University of Minnesota Medical School, Minneapolis, Minnesota; Department of Family Medicine and Community Health, University of Minnesota Medical School, Minneapolis, Minnesota.

Show MeSH

Related in: MedlinePlus

Participant flow chart. *One participant in the clinic group was assigned to clinic but given kit and returned it. This person was removed from the analysis. **There are two additional kits from the Home group that were returned after the 3-month time frame; their outcomes are not included in this analysis.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4402076&req=5

fig01: Participant flow chart. *One participant in the clinic group was assigned to clinic but given kit and returned it. This person was removed from the analysis. **There are two additional kits from the Home group that were returned after the 3-month time frame; their outcomes are not included in this analysis.

Mentions: Of the 242 women screened for the study, 75 (31%) were eligible and 11 declined to participate (Fig.1). Most women who attended the screening sessions were ineligible based on several reasons; a recent Pap smear (within 3 years), unknown Pap history, and history of hysterectomy. A total of 64 women were enrolled and randomized; 32 to the clinic-based Pap group and 32 to the home-based HPV group. One participant in the clinic-based Pap group was removed from analysis due to a protocol violation.


Cervical cancer screening with clinic-based Pap test versus home HPV test among Somali immigrant women in Minnesota: a pilot randomized controlled trial.

Sewali B, Okuyemi KS, Askhir A, Belinson J, Vogel RI, Joseph A, Ghebre RG - Cancer Med (2015)

Participant flow chart. *One participant in the clinic group was assigned to clinic but given kit and returned it. This person was removed from the analysis. **There are two additional kits from the Home group that were returned after the 3-month time frame; their outcomes are not included in this analysis.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4402076&req=5

fig01: Participant flow chart. *One participant in the clinic group was assigned to clinic but given kit and returned it. This person was removed from the analysis. **There are two additional kits from the Home group that were returned after the 3-month time frame; their outcomes are not included in this analysis.
Mentions: Of the 242 women screened for the study, 75 (31%) were eligible and 11 declined to participate (Fig.1). Most women who attended the screening sessions were ineligible based on several reasons; a recent Pap smear (within 3 years), unknown Pap history, and history of hysterectomy. A total of 64 women were enrolled and randomized; 32 to the clinic-based Pap group and 32 to the home-based HPV group. One participant in the clinic-based Pap group was removed from analysis due to a protocol violation.

Bottom Line: Test completion rates were measured at 3 months.Univariate and multivariate logistic regression models were used to explore factors associated with test completion (intention-to-treat analysis).Participants in the HPV test group were 14 times more likely to complete the test compared to those in the Pap test group (P = 0.0002).

View Article: PubMed Central - PubMed

Affiliation: Program in Health Disparities Research, University of Minnesota Medical School, Minneapolis, Minnesota; Department of Family Medicine and Community Health, University of Minnesota Medical School, Minneapolis, Minnesota.

Show MeSH
Related in: MedlinePlus